We provide you with 20 years of free, institutional-grade data for CMMB stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of CMMB. Explore the full financial landscape of CMMB stock.
| Reported Date | CIK | Ticker | Type |
|---|
Chemomab Therapeutics Ltd(NASDAQ:CMMB) 
Chemomab Therapeutics Ltd. engages in the research and development of biological drugs for the treatment of inflammatory and fibrotic diseases. The company was formerly known as Anchiano Therapeutics Ltd. and changed its name to Chemomab Therapeutics Ltd. in March 16, 2021. Chemomab Therapeutics Ltd...
Share this website to your friends
The information provided in this report about CMMB stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.